Camden National Bank Vertex Pharmaceuticals Inc Transaction History

Camden National Bank

$699 Million
Q3 2025

A detailed history of Camden National Bank transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Camden National Bank holds 20,892 shares of VRTX stock, worth $9.07 Million. This represents 1.17% of its overall portfolio holdings.

Number of Shares

20,892

Previous 20,462 2.1%

Holding current value

$9.07 Million

Previous $9.11 Million 10.18%

% of portfolio

1.17%

Previous 1.35%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 06, 2025	BUY	$366.54 - $479.53 $157,612 - $206,197	430 Added 2.1%	20,892 $8.18 Million
Q2 2025 Aug 12, 2025	SELL	$421.16 - $509.5 $85,916 - $103,938	-204 Reduced 0.99%	20,462 $9.11 Million
Q1 2025 May 13, 2025	SELL	$402.49 - $513.76 $109,074 - $139,228	-271 Reduced 1.29%	20,666 $10 Million
Q4 2024 Feb 07, 2025	SELL	$396.64 - $516.74 $74,171 - $96,630	-187 Reduced 0.89%	20,937 $8.43 Million
Q3 2024 Nov 12, 2024	SELL	$460.0 - $505.78 $86,480 - $95,086	-188 Reduced 0.88%	21,124 $9.82 Million

Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $1.08 Million - $1.33 Million	2,742 Added 14.77%	21,312 $9.99 Million
Q1 2024 Apr 30, 2024	SELL	$407.69 - $446.08 $239,721 - $262,295	-588 Reduced 3.07%	18,570 $7.76 Million
Q4 2023 Feb 12, 2024	SELL	$343.0 - $410.68 $171,500 - $205,340	-500 Reduced 2.54%	19,158 $7.8 Million
Q3 2023 Nov 03, 2023	BUY	$338.18 - $362.46 $356,103 - $381,670	1,053 Added 5.66%	19,658 $6.84 Million
Q2 2023 Aug 09, 2023	SELL	$314.42 - $351.91 $85,522 - $95,719	-272 Reduced 1.44%	18,605 $6.55 Million
Q1 2023 May 08, 2023	SELL	$283.23 - $323.1 $57,495 - $65,589	-203 Reduced 1.06%	18,877 $5.95 Million
Q4 2022 Feb 10, 2023	SELL	$285.76 - $321.48 $99,444 - $111,875	-348 Reduced 1.79%	19,080 $5.51 Million
Q3 2022 Nov 04, 2022	SELL	$273.83 - $305.53 $24,918 - $27,803	-91 Reduced 0.47%	19,428 $5.63 Million
Q2 2022 Aug 09, 2022	BUY	$234.96 - $292.55 $47,931 - $59,680	204 Added 1.06%	19,519 $5.5 Million
Q1 2022 May 05, 2022	SELL	$221.42 - $260.97 $108,938 - $128,397	-492 Reduced 2.48%	19,315 $5.04 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $49,739 - $62,789	281 Added 1.44%	19,807 $4.35 Million
Q3 2021 Nov 09, 2021	SELL	$181.39 - $202.99 $1.2 Million - $1.34 Million	-6,606 Reduced 25.28%	19,526 $3.54 Million
Q2 2021 Aug 09, 2021	SELL	$187.49 - $221.1 $230,987 - $272,395	-1,232 Reduced 4.5%	26,132 $5.27 Million
Q1 2021 Aug 04, 2021	SELL	$207.02 - $241.31 $6,417 - $7,480	-31 Reduced 0.11%	27,364 $5.88 Million
Q4 2020 Feb 01, 2021	BUY	$207.01 - $276.09 $2.39 Million - $3.19 Million	11,561 Added 73.01%	27,395 $6.47 Million
Q3 2020 Nov 05, 2020	BUY	$255.65 - $303.1 $2.2 Million - $2.61 Million	8,617 Added 119.4%	15,834 $4.31 Million
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $1.63 Million - $2.13 Million	7,217 New	7,217 $2.1 Million

Others Institutions Holding VRTX

# of Institutions

1,789

Shares Held

231M

Call Options Held

1.83M

Put Options Held

1.21M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $111B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Camden National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Camden National Bank with notifications on news.

Account

Camden National Bank Vertex Pharmaceuticals Inc Transaction History